Does repatha work?

What is Repatha and what does it treat?
Repatha, also known as evolocumab, is a medication used to treat high cholesterol, specifically very high levels of low-density lipoprotein (LDL) cholesterol. It is an injectable prescription medicine administered every 2 weeks or monthly [1].

How does Repatha work?
Repatha is a monoclonal antibody that targets PCSK9, a protein involved in cholesterol production in the liver. By blocking PCSK9, Repatha helps reduce the amount of LDL cholesterol in the blood [2].

Does Repatha work for everyone?
Clinical trials have shown that Repatha can effectively lower LDL cholesterol in most patients with high cholesterol. However, patient responses to the medication can vary, and individual results may differ [3].

What are the benefits of Repatha?
Studies have demonstrated that Repatha can significantly reduce the risk of cardiovascular events, such as heart attacks and strokes, in patients with high cholesterol. Repatha was also shown to increase high-density lipoprotein (HDL) cholesterol, a "good" type of cholesterol [4].

When and how is Repatha administered?
Repatha is typically administered every 2 weeks or monthly, and patients should follow the treatment schedule as prescribed by their doctor. Self-administration is also possible with the guidance of a healthcare professional [5].

Common side effects of Repatha
Some patients may experience side effects when taking Repatha, including injection site reactions, muscle and bone pain, and flu-like symptoms. Patients should discuss these potential side effects with their doctor before starting treatment [6].

Patent and exclusivity information
Repatha's patent is set to expire in 2028, after which biosimilar versions may enter the market [7].

Sources:

[1] Repatha (evolocumab) - www.drugpatentwatch.com

[2] ClinicalTrials.gov: Study of Evolocumab in Patients With Heterozygous Familial Hypercholesterolemia (RUTAN)

[3] JAMA: Efficacy and safety of evolocumab in lowering LDL cholesterol in patients at risk of cardiovascular disease

[4] NEJM: Effects of Evolocumab on Lipid Parameters in Patients With Atherosclerotic Cardiovascular Disease

[5] Repatha Official Website: www.repatha.com

[6] Repatha (evolocumab) Prescribing Information: Amgen

[7] www.drugpatentwatch.com: Repatha (evolocumab) Patent Expiration